CXC chemokine receptor 1 predicts postoperative prognosis and chemotherapeutic benefits for TNM II and III resectable gastric cancer patients

BACKROUND: Abnormal expression of CXC chemokine receptor 1 (CXCR1) has shown the ability to promote tumor angiogensis, invasion and metastasis in several cancers. The purpose of our curret study is to discover the clinical prognostic significance of CXCR1 in resectable gastric cancer. METHODS: 330 g...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yifan, Liu, Hao, Zhang, Heng, Lin, Chao, Li, Ruochen, Wu, Songyang, Li, He, He, Hongyong, Zhang, Weijuan, Xu, Jiejie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386765/
https://www.ncbi.nlm.nih.gov/pubmed/27780937
http://dx.doi.org/10.18632/oncotarget.12815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386765/
https://www.ncbi.nlm.nih.gov/pubmed/27780937
http://dx.doi.org/10.18632/oncotarget.12815

Ejemplares similares